Gomiero Mirella Basolli Sells 10,000 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) VP Gomiero Mirella Basolli sold 10,000 shares of Afya stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $14.80, for a total value of $148,000.00. Following the sale, the vice president directly owned 34,530 shares in the company, valued at $511,044. The trade was a 22.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Afya Trading Up 1.1%

Shares of AFYA opened at $15.00 on Thursday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. The stock has a market cap of $1.41 billion, a PE ratio of 9.80, a PEG ratio of 1.52 and a beta of 0.32. Afya Limited has a 1 year low of $13.00 and a 1 year high of $18.01. The stock has a 50 day simple moving average of $14.30 and a 200-day simple moving average of $14.53.

Institutional Trading of Afya

Hedge funds and other institutional investors have recently made changes to their positions in the business. Daiwa Securities Group Inc. bought a new position in shares of Afya in the fourth quarter valued at about $43,000. Militia Capital Partners LP acquired a new stake in Afya in the 2nd quarter valued at about $71,000. Quantbot Technologies LP bought a new position in shares of Afya in the second quarter worth about $117,000. State of Wyoming acquired a new position in shares of Afya during the second quarter worth approximately $164,000. Finally, Van ECK Associates Corp lifted its position in shares of Afya by 15.7% during the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after purchasing an additional 1,377 shares in the last quarter. 88.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on AFYA shares. Bank of America reissued a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. reduced their price target on shares of Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a report on Monday, April 20th. One investment analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $17.10.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.